Abstract:Background B-lymphoma Moloney murine leukemia virus insertion region-1 (Bmi-1) acts as an oncogene in various tumors, and its overexpression correlates with a poor outcome in several human cancers. Ectopic expression of Bmi-1 can induce epithelial-mesenchymal transition (EMT) and enhance the motility and invasiveness of human nasopharyngeal epithelial cells (NPECs), whereas silencing endogenous Bmi-1 expression can reverse EMT and reduce the metastatic potential of nasopharyngeal cancer cells (NPCs). Mouse xenograft studies indicate that coexpression of Bmi-1 and H-Ras in breast cancer cells can induce an aggressive and metastatic phenotype with an unusual occurrence of brain metastasis; although, Bmi-1 overexpression did not result in oncogenic transformation of MCF-10A cells. However, the underlying molecular mechanism of Bmi-1-mediated progression and the metastasis of breast cancer are not fully elucidated at this time. Results Bmi-1 expression is more pronouncedly increased in primary cancer tissues compared to matched adjacent non-cancerous tissues. High Bmi-1 expression is correlated with advanced clinicopathologic classifications (T, N, and M) and clinical stages. Furthermore, a high level of Bmi-1 indicates an unfavorable overall survival and serves as a high risk marker for breast cancer. In addition, inverse transcriptional expression levels of Bmi-1 and E-cadherin are detected between the primary cancer tissues and the matched adjacent non-cancerous tissues. Higher Bmi-1 levels are found in the cancer tissue, whereas the paired adjacent non-cancer tissue shows higher E-cadherin levels. Overexpression of Bmi-1 increases the motility and invasive properties of immortalized human mammary epithelial cells, which is concurrent with the increased expression of mesenchymal markers, the decreased expression of epithelial markers, the stabilization of Snail and the dysregulation of the Akt/GSK3β pathway. Consistent with these observations, the repression of Bmi-1 in highly metastatic breast cancer cells remarkably reduces cellular motility, invasion and transformation, as well as tumorigenesis and lung metastases in nude mice. In addition, the repression of Bmi-1 reverses the expression of EMT markers and inhibits the Akt/GSK3β/Snail pathway. Conclusions This study demonstrates that Bmi-1 promotes the invasion and metastasis of human breast cancer and predicts poor survival.

Bmi-1 Promotes Invasion and Metastasis, and Its Elevated Expression is Correlated with an Advanced Stage of Breast Cancer

[Association of Bmi-1 Expression with Clinicopathological Features and Prognosis of Colorectal Cancer].

Expression and clinical significance of Bmi-1 in colorectal cancer

Bmi-1 Expression Modulates Non-Small Cell Lung Cancer Progression.

Bmi1 Drives Stem-Like Properties and is Associated with Migration, Invasion, and Poor Prognosis in Tongue Squamous Cell Carcinoma

[Expression and Significance of Bmi-1 in Breast Cancer].

Bmi-1 Is Related To Proliferation, Survival And Poor Prognosis In Pancreatic Cancer

Overexpression of Bmi-1 Contributes to the Invasion and Metastasis of Hepatocellular Carcinoma by Increasing the Expression of Matrix Metalloproteinase (MMP)-2, MMP-9 and Vascular Endothelial Growth Factor Via the PTEN/PI3K/Akt Pathway

Overexpression of Bmi-1 mRNA predicts the progression and metastasis of liver cancer

Bmi-1 is Critical for the Proliferation and Invasiveness of Gastric Carcinoma Cells

BMI‐1 promotes breast cancer proliferation and metastasis through different mechanisms in different subtypes

Bmi-1 Promotes the Chemoresistance, Invasion and Tumorigenesis of Pancreatic Cancer Cells

Expression of Bmi-1 is a Prognostic Marker in Bladder Cancer.

Overexpression of Bmi-1 in Uterine Cervical Cancer: Correlation with Clinicopathology and Prognosis.

Bmi-1 promotes the aggressiveness of glioma via activating the NF-kappaB/MMP-9 signaling pathway

The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells.

Expression Level of Bmi-1 Oncoprotein is Associated with Progression and Prognosis in Colon Cancer

Bmi-1 Expression on Colorectal Cancer Tissue and Its Clinical Significance

Bmi-1 is a Novel Molecular Marker of Nasopharyngeal Carcinoma Progression and Immortalizes Primary Human Nasopharyngeal Epithelial Cells

The Crucial Roles of Bmi-1 in Cancer: Implications in Pathogenesis, Metastasis, Drug Resistance, and Targeted Therapies

Bmi-1,a Polycomb Group Protein,Plays an Essential Role in Tumorigenesis and Metastasis